Schotten U, Verheule S, Kirchhof P, Goette A: Pathophysiological mechanisms of atrial fibrillation: a translational appraisal. Physiol Rev. 2011, 91: 265-325.
Article
PubMed
Google Scholar
Wakili R, Voigt N, Kääb S, Dobrev D, Nattel S: Recent advances in the molecular pathophysiology of atrial fibrillation. J Clin Invest. 2011, 121: 2955-2968.
Article
PubMed Central
CAS
PubMed
Google Scholar
Chamberlain AM, Agarwal SK, Ambrose M, Folsom AR, Soliman EZ, Alonso A: Metabolic syndrome and incidence of atrial fibrillation among blacks and whites in the Atherosclerosis Risk in Communities (ARIC) Study. Am Heart J. 2010, 159: 850-856.
Article
PubMed Central
PubMed
Google Scholar
Tanner RM, Baber U, Carson AP, Voeks J, Brown TM, Soliman EZ, Howard VJ, Muntner P: Association of the metabolic syndrome with atrial fibrillation among United States adults (from the REasons for Geographic and Racial Differences in Stroke (REGARDS) Study). Am J Cardiol. 2011, 108: 227-232.
Article
PubMed Central
PubMed
Google Scholar
Shigematsu Y, Hamada M, Nagai T, Nishimura K, Inoue K, Suzuki J, Ogimoto A, Higaki J: Risk for atrial fibrillation in patients with hypertrophic cardiomyopathy: association with insulin resistance. J Cardiol. 2011, 58: 18-25.
Article
PubMed
Google Scholar
Aviles RJ, Martin DO, Apperson-Hansen C, Houghtaling PL, Rautaharju P, Kronmal RA, Tracy RP, Van Wagoner DR, Psaty BM, Lauer MS, Chung MK: Inflammation as a risk factor for atrial fibrillation. Circulation. 2003, 108: 3006-3010.
Article
PubMed
Google Scholar
Isoda K, Young JL, Zirlik A, MacFarlane LA, Tsuboi N, Gerdes N, Schönbeck U, Libby P: Metformin inhibits proinflammatory responses and nuclear factor-kappaB in human vascular wall cells. Arterioscler Thromb Vasc Biol. 2006, 26: 611-617.
Article
CAS
PubMed
Google Scholar
Arai M, Uchiba M, Komura H, Mizuochi Y, Harada N, Okajima K: Metformin, an antidiabetic agent, suppresses the production of tumor necrosis factor and tissue factor by inhibiting early growth response factor-1 expression in human monocytes in vitro. J Pharmacol Exp Ther. 2010, 334: 206-213.
Article
CAS
PubMed
Google Scholar
Calixto MC, Lintomen L, André DM, Leiria LO, Ferreira D, Lellis-Santos C, Anhê GF, Bordin S, Landgraf RG, Antunes E: Metformin attenuates the exacerbation of the allergic eosinophilic inflammation in high fat-diet-induced obesity in mice. PLoS One. 2013, 8: e76786-
Article
PubMed Central
CAS
PubMed
Google Scholar
Lin C-F, Young K-C, Bai C-H, Yu B-C, Ma C-T, Chien Y-C, Su H-C, Wang H-Y, Liao C-S, Lai H-W, Tsao C-W: Blockade of reactive oxygen species and Akt activation is critical for anti-inflammation and growth inhibition of Metformin in Phosphatase and Tensin Homolog-Deficient RAW264.7 Cells. Immunopharm Immunot. 2013, 35: 669-677.
Article
CAS
Google Scholar
Salman ZK, Refaat R, Selima E, El Sarha A, Ismail MA: The combined effect of metformin and L-cysteine on inflammation, oxidative stress and insulin resistance in streptozotocin-induced type 2 diabetes in rats. Eur J Pharmacol. 2013, 714: 448-455.
Article
CAS
PubMed
Google Scholar
Park CS, Bang B-R, Kwon H-S, Moon K-A, Kim T-B, Lee K-Y, Moon H-B, Cho YS: Metformin reduces airway inflammation and remodeling via activation of AMP-activated protein kinase. Biochem Pharmacol. 2012, 84: 1660-1670.
Article
CAS
PubMed
Google Scholar
Klempfner R, Leor J, Tenenbaum A, Fisman EZ, Goldenberg I: Effects of a vildagliptin/metformin combination on markers of atherosclerosis, thrombosis, and inflammation in diabetic patients with coronary artery disease. Cardiovasc Diabetol. 2012, 11: 60-
Article
PubMed Central
CAS
PubMed
Google Scholar
Fidan E, Onder Ersoz H, Yilmaz M, Yilmaz H, Kocak M, Karahan C, Erem C: The effects of rosiglitazone and metformin on inflammation and endothelial dysfunction in patients with type 2 diabetes mellitus. Acta Diabetol. 2011, 48: 297-302.
Article
CAS
PubMed
Google Scholar
Yeh Y-H, Kuo C-T, Chan T-H, Chang G-J, Qi X-Y, Tsai F, Nattel S, Chen W-J: Transforming growth factor-β and oxidative stress mediate tachycardia-induced cellular remodelling in cultured atrial-derived myocytes. Cardiovasc Res. 2011, 91: 62-70.
Article
CAS
PubMed
Google Scholar
Lin CH, Sheu WHH: Hypoglycaemic episodes and risk of dementia in diabetes mellitus: 7-year follow-up study. J Intern Med. 2013, 273: 102-110.
Article
PubMed
Google Scholar
Lin C-C, Li C-I, Hsiao C-Y, Liu C-S, Yang S-Y, Lee C-C, Li T-C: Time trend analysis of the prevalence and incidence of diagnosed type 2 diabetes among adults in Taiwan from 2000 to 2007: a population-based study. BMC Public Health. 2013, 13: 318-
Article
PubMed Central
PubMed
Google Scholar
Chen S-W, Tsan Y-T, Chen J-D, Hsieh H-I, Lee C-H, Lin H-H, Wang J-D, Chen P-C: Use of thiazolidinediones and the risk of colorectal cancer in patients with diabetes: a nationwide, population-based, case–control study. Diabetes Care. 2013, 36: 369-375.
Article
PubMed Central
CAS
PubMed
Google Scholar
Chao T-F, Leu H-B, Huang C-C, Chen J-W, Chan W-L, Lin S-J, Chen S-A: Thiazolidinediones can prevent new onset atrial fibrillation in patients with non-insulin dependent diabetes. Int J Cardiol. 2012, 156: 199-202.
Article
PubMed
Google Scholar
Burstein B, Qi X-Y, Yeh Y-H, Calderone A, Nattel S: Atrial cardiomyocyte tachycardia alters cardiac fibroblast function: a novel consideration in atrial remodeling. Cardiovasc Res. 2007, 76: 442-452.
Article
CAS
PubMed
Google Scholar
Nattel S, Maguy A, Le Bouter S, Yeh Y-H: Arrhythmogenic ion-channel remodeling in the heart: heart failure, myocardial infarction, and atrial fibrillation. Physiol Rev. 2007, 87: 425-456.
Article
CAS
PubMed
Google Scholar
Yeh Y-H, Kuo C-T, Lee Y-S, Lin Y-M, Nattel S, Tsai F-C, Chen W-J: Region-specific gene expression profiles in the left atria of patients with valvular atrial fibrillation. Heart Rhythm. 2013, 10: 383-391.
Article
PubMed
Google Scholar
Watanabe H, Tanabe N, Watanabe T, Darbar D, Roden DM, Sasaki S, Aizawa Y: Metabolic syndrome and risk of development of atrial fibrillation: the Niigata preventive medicine study. Circ. 2008, 117: 1255-1260.
Article
Google Scholar
Dernellis J, Panaretou M: Relationship between C-reactive protein concentrations during glucocorticoid therapy and recurrent atrial fibrillation. Eur Heart J. 2004, 25: 1100-1107.
Article
CAS
PubMed
Google Scholar
Dernellis J, Panaretou M: Effect of C-reactive protein reduction on paroxysmal atrial fibrillation. Am Heart J. 2005, 150: 1064-
Article
PubMed
Google Scholar
Nicolaou VN, Papadakis JE, Karatzis EN, Dermitzaki SI, Tsakiris AK, Skoufas PD: Impact of the metabolic syndrome on atrial size in patients with new-onset atrial fibrillation. Angiol. 2007, 58: 21-25.
Article
Google Scholar
Ialenti A, Grassia G, Di Meglio P, Maffia P, Di Rosa M, Ianaro A: Mechanism of the anti-inflammatory effect of thiazolidinediones: relationship with the glucocorticoid pathway. Mol Pharmacol. 2005, 67: 1620-1628.
Article
CAS
PubMed
Google Scholar
Buckingham RE: Thiazolidinediones: Pleiotropic drugs with potent anti-inflammatory properties for tissue protection. Hepatol Res J Japan Soc Hepatol. 2005, 33: 167-170.
Article
CAS
Google Scholar
Ceriello A: Thiazolidinediones as anti-inflammatory and anti-atherogenic agents. Diabetes Metab Res Rev. 2008, 24: 14-26.
Article
CAS
PubMed
Google Scholar
Koufany M, Moulin D, Bianchi A, Muresan M, Sebillaud S, Netter P, Weryha G, Jouzeau J-Y: Anti-inflammatory effect of antidiabetic thiazolidinediones prevents bone resorption rather than cartilage changes in experimental polyarthritis. Arthritis Res Ther. 2008, 10: R6-
Article
PubMed Central
PubMed
Google Scholar
Abdulkadir AAA, Thanoon IA-J: Comparative effects of glibenclamide and metformin on C-reactive protein and oxidant/antioxidant status in patients with type II diabetes mellitus. Sultan Qaboos Univ Med J. 2012, 12: 55-61.
Article
PubMed Central
PubMed
Google Scholar